What is the Biorestorative Therapies Inc. stock price forecast?

Biorestorative Therapies Inc. is currently trading at $0.43. View real-time AI analysis on Alpha Lenz.

What is Biorestorative Therapies Inc. insider trading activity?

View the latest insider trading data for Biorestorative Therapies Inc. on Alpha Lenz.

What is Biorestorative Therapies Inc.'s P/E ratio?

Biorestorative Therapies Inc.'s P/E ratio is -0.3.

Biorestorative Therapies Inc.

NASDAQ · BRTX

$0.43+0.18(+73.30%)Pre-market

Ask about Biorestorative Therapies Inc.'s future dividend policy...

Alpha Chat Insight

“Biorestorative Therapies Inc. trades at a P/E of -0.3 (undervalued) with modest ROE of -320.5%. 3Y revenue CAGR of 44.3% highlights clear growth momentum.”

Ask for details →

Company Overview

Biorestorative Therapies Inc. operates within the biotechnology and medical research sector, focusing specifically on the development of therapeutic products using cell and tissue treatment technologies. The company's primary efforts are directed towards advancing stem cell therapies, with substantial research into treatments for chronic lumbar disc disease and metabolic disorders like obesity and diabetes. By pioneering innovative approaches in regenerative medicine, Biorestorative Therapies Inc. seeks to address unmet medical needs and improve the quality of life for patients. The company targets multiple areas within the healthcare industry, collaborating with research institutions and healthcare providers to enhance its research capabilities and potential market applications. Biorestorative Therapies Inc.'s work significantly contributes to the evolving landscape of biopharmaceuticals, playing a crucial role in the ongoing development of cutting-edge medical therapies.

CEOMr. Lance Alstodt

Websitehttps://www.biorestorative.com

SectorHealthcare

IndustryBiotechnology

Employees11

Company Statistics

FY 2025

Profile

$3.89MMarket Cap

$359.70KRevenue

0.00Shares Out

11Employees

Margins

93.37%Gross

-4603.46%EBITDA

-4350.05%Operating

-3959.40%Pre-Tax

-3959.40%Net

Valuation

-0.27P/E

10.91P/B

10.82EV/Sales

-0.14EV/EBITDA

-0.36P/FCF

Growth (CAGR)

44.27%Rev 3Yr

36.11%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-174.11%ROA

-320.47%ROE

-191.29%ROIC

Financial Health

$1.51MCash & Cash Equivalents

$2.21MNet Debt

1043.57%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Biorestorative Therapies Inc. trades at a P/E of -0.3 (undervalued) with modest ROE of -320.5%. 3Y revenue CAGR of 44.3% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Biorestorative Therapies Inc. (ticker: BRTX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 11 employees. Market cap is $4M.

The current price is $0.433 with a P/E ratio of -0.27x and P/B of 10.91x.

ROE is -320.47% and operating margin is -4350.05%. Annual revenue is $359,700.